NCT06918756 Development of a Cough Control Questionnaire (CCQ)
| NCT ID | NCT06918756 |
| Status | Recruiting |
| Phase | — |
| Sponsor | King's College Hospital NHS Trust |
| Condition | Cough |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2031-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-04-01 with a primary completion date of 2031-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chronic cough (\>8 weeks in duration) affects 5-12% of the global population, and is associated with considerable health status impairment and comorbidities. Currently, there are validated severity and impact outcome measures whilst objective measures with cough frequency monitoring is not available in routine clinical practice. Unlike other chronic respiratory diseases, namely asthma, there are no validated dedicated tools to assess the control of cough as a disease. This study aims to develop a validated patient-focused tool to assess the control of cough, which may be useful to evaluate the benefit and value of treatments in both clinical and research settings.
Eligibility Criteria
Inclusion Criteria: * Adult patients aged 18 and over with acute and chronic cough (including refractory chronic cough and unexplained chronic cough) and able to read and write in English. A smaller number (n =20) of healthy volunteers will also be included with no evidence of significant respiratory disease. Exclusion Criteria: * Current smokers (or smoking within the last 12 months), respiratory tract infection within the last 4 weeks, use of angiotensin converting enzyme inhibitors (ACEi), and pregnancy
Frequently Asked Questions
Who can join the NCT06918756 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Cough. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06918756 currently recruiting?
Yes, NCT06918756 is actively recruiting participants. Visit ClinicalTrials.gov or contact King's College Hospital NHS Trust to inquire about joining.
Where is the NCT06918756 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT06918756 clinical trial?
NCT06918756 is sponsored by King's College Hospital NHS Trust. The trial plans to enroll 100 participants.